Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

Orchid - Fighting Male Cancer have launched their latest prostate cancer campaign that aims to grab the attention of potential prostate cancer patients and their loved ones to educate them on the key ...

Tom Nolan reviews this week’s research When it comes to peripherally inserted lines for outpatient parenteral antimicrobial ...

The Prince of Wales’ comments on Nov. 20 follow a “brutal” year that saw his own father and partner both diagnosed with ...

said about 250,000 men are expected to be diagnosed with prostate cancer in the U.S. next year. But if caught quickly enough, ...

Celebrated annually on November 19th, International Men's Day acknowledges the positive contributions of men globally. The 2024 theme, "Positive Male Role Models," emphasizes the importance of men's ...

New analysis from the DETECT-A study supports MCED testing as a complement to current guideline-recommended screening in lung ...

He will largely focus on cancer research at Sanford Burnham Prebys, drawing on his experience with numerous projects ...

Then, as television arrived in the Fifties and Sixties, football took its nervous first steps into the medium, and Match of ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.